OTC/Dietary Supplement Combination Guidance “Unlikely” – FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA has no near-term plans to issue a formal guidance on dietary supplement/OTC combination products
You may also be interested in...
B.F. Ascher Halts Supplement/OTC Combo Sales Following FDA Warnings
B.F. Ascher has discontinued the sale of its Melagesic PM dietary supplement/OTC combination in response to FDA's decision the product is an unapproved new drug, according to the agency
B.F. Ascher Halts Supplement/OTC Combo Sales Following FDA Warnings
B.F. Ascher has discontinued the sale of its Melagesic PM dietary supplement/OTC combination in response to FDA's decision the product is an unapproved new drug, according to the agency
B.F. Ascher Halts Supplement/OTC Combo Sales Following FDA Warnings
B.F. Ascher has discontinued the sale of its Melagesic PM dietary supplement/OTC combination in response to FDA's decision the product is an unapproved new drug, according to the agency